Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Mindfulness-Based Intervention for Adolescents (Mindfulteen)

14 gennaio 2021 aggiornato da: Camille Nemitz Piguet, University of Geneva, Switzerland

Early Mindfulness-based Intrevention for Anxious Adolescents: a fMRI Randomized Controlled Trial

The Mindfulteen Study is a 3-year long longitudinal cohort study with a nested randomized controlled trial, integrating neuroimaging, biological and clinical outcomes, and designed to evaluate the impact of a mindfulness-based intervention (MBI) on young adolescents.

Young adolescents between 13 and 15 years with no history of current mental health disorder (with the exception for anxiety symptoms) or of psychotherapy are included and randomized to either early or late intervention (i.e. waiting list or control group), after being stratified between low or high anxiety group based on State and Trait Anxiety Inventory (STAI-T) score. Participants on the control group participate on MBI after completing the second assessment. The intervention is an 8-week long MBI adapted to adolescents. Primary outcomes are based on neuroimaging (structural and functional MRI) and secondary outcomes are clinical (self-reported questionnaires covering mostly emotion and stress reactivity and trait mindfulness) and biological (cortisol, inflammation markers and redox markers). Assessments are performed at baseline, immediately after intervention or waiting time and after 18 months of intervention.

Panoramica dello studio

Descrizione dettagliata

Promotion of mental health is a major concern worldwide, particularly among young population as major psychiatric diseases can have their onset during adolescence and young adulthood. During adolescence, there is growing evidence that "at-risk" states for mental disorders, as high stress reactivity for example, can be identified prior to clinical symptoms, and that early interventions can have a major impact preventing the further development of full-blown mental illness.

In the last two decades, given a growing interest for non-pharmacological approaches to improve mental and physical health, mindfulness-based interventions (MBI) have received serious attention. After the initial applications on chronic pain, stress reduction and prevention of depressive relapses, MBIs are now widely implemented among clinical and non-clinical populations.

Therefore, investigators aim to better understand the modifications of brain circuits involved in the emergence of stress related disorders and the impact of a MBI on those circuits. Hence, a translational project was designed, integrating neuroimaging, biological and clinical outcomes of stress reactivity to evaluate the impact of a MBI on adolescents.

The Mindfulteen Study is a 3-year longitudinal cohort study with a nested randomized controlled trial. The randomized controlled trial part of the study was designed to assess the clinical effect of MBI on adolescents, comparing to a control group. Therefore, after inclusion participants are electronically randomized between either early intervention group or late intervention group (i.e., waiting list or control group). Participants allocated in the late intervention group engage in MBI after the waiting period, providing data also for the longitudinal cohort part of the study and therefore increasing the data available for before and after comparison. The long-term effect of MBI will be assessed after 18 months of intervention.

Before randomization, participants are stratified according to their score on the trait questionnaire of the State Trait Anxiety Inventory (STAI) as low anxiety group (≤ 31) or high anxiety group (>31).

Assessments are performed before intervention, immediately after intervention or waiting period and in 18 months. For the late intervention group, an additional assessment is performed immediately after the intervention.

The overall objective of the Mindfulteen Study is to assess the immediate and long-term effect of an MBI on reactivity to stress and anxiety, in a non-clinical sample of young adolescents from the general population. Underlying psychological and biological changes are assessed using a multimodal brain MRI protocol, blood and hair sampling, as well as physiological measurements of stress.

The primary aim is to characterize brain functional modifications in cortico-limbic and cortico-striatal-thalamic circuits (functional MRI data) and their underlying neuroanatomical changes (analysis of structural, spectroscopy and diffusion MRI data) in adolescents exposed to MBI, comparing adolescents with high anxiety and low anxiety levels.

Secondary aims include the effects of MBI on self-reported levels of anxiety, emotion regulation strategies (clinical scores) and physiological markers of hypothalamic-pituitary-adrenal axis (hair cortisol), as well as biological markers of oxidative stress and inflammation (blood sampling).

Tipo di studio

Interventistico

Iscrizione (Anticipato)

120

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 13 anni a 15 anni (Bambino)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 13 to 15 year-old
  • Interest in participating in a mindfulness based intervention
  • Francophone
  • Have access to internet and a to a compatible device (smartphone or tablet) every day to run the study's application
  • Availability for the study duration
  • Consent documented by signature and support from the legal representatives as documented by a signature
  • Informed Consent as documented by a signature

Exclusion Criteria:

  • History of chronic somatic disease or clinically significant medical condition (e.g., asthma, diabetes, renal failure, hepatic dysfunction, etc.)
  • History of neurologic or major psychiatric disease (except for an anxious disorder without comorbidity and a history of major depressive episode resolved for at least 6 months).
  • History of psychotherapy in the past 6 months
  • History of regular meditation practice
  • Women who are pregnant or breast feeding
  • Known or suspected non-compliance, drug or alcohol abuse,
  • Inability to participate in group sessions,
  • Previous enrolment into the current study
  • Inability to undergo study's procedures (IRM and blood sample collection)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Early Mindfulness Intervention
The Early MBI group partake on the mindfulness intervention after first outcome assessment.

The proposed MBI is an adaptation from the Mindfulness Based Stress Reduction (MBSR) and Mindfulness based Cognitive Therapy (MBCT) programs to youth. This MBI consists of a total of twelve 90 minutes long sessions, the first 8 being the intervention per se and the last 4 a proposition to the transition to regular practice and a chance to better integrate mindfulness in daily life.

A theme regarding mindfulness is addressed in each session, through meditation practices and exercises. Between sessions, participants are invited to practice at home, using an application designed for this study (the MindApp), where participants can find the recorded practices. Investigators have access to participants' use of the meditation recordings and expect that these data will provide a more objective measure of the amount of home practice.

Comparatore placebo: Late Mindfulness Intervention

The Late MBI group partake on the mindfulness intervention after the second outcome assessment.

This groups is the control group for the Early MBI group.

After the second assessment, this group engage on the same intervention as the early group.

The proposed MBI is an adaptation from the Mindfulness Based Stress Reduction (MBSR) and Mindfulness based Cognitive Therapy (MBCT) programs to youth. This MBI consists of a total of twelve 90 minutes long sessions, the first 8 being the intervention per se and the last 4 a proposition to the transition to regular practice and a chance to better integrate mindfulness in daily life.

A theme regarding mindfulness is addressed in each session, through meditation practices and exercises. Between sessions, participants are invited to practice at home, using an application designed for this study (the MindApp), where participants can find the recorded practices. Investigators have access to participants' use of the meditation recordings and expect that these data will provide a more objective measure of the amount of home practice.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Brain activity in stress-related networks at functional MRI
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change of the fronto-limbic circuit recovery after a social laboratory stress using the Montreal Imaging Stress Task (MIST)
At baseline, immediately after intervention, 18 months after intervention
Brain gray matter at structural MRI
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on gray matter volume in prefrontal areas
At baseline, immediately after intervention, 18 months after intervention
Brain connectivity at functional MRI
Lasso di tempo: Before and after intervention
Change in structural connectivity measures between prefrontal and limbic areas after intervention
Before and after intervention
Brain cortical thickness at structural MRI
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Cortical thickness in prefrontal areas
At baseline, immediately after intervention, 18 months after intervention

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Level of anxiety
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change of the level of anxiety measured by the State and Trait Anxiety Inventory. Minimum score 20, maximum score 60. Higher score means a worse outcome (higher anxiety).
At baseline, immediately after intervention, 18 months after intervention
Level of emotional awareness
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline Emotion Awareness Questionnaire score after intervention. Minimum score 0, maximum score 40. Higher score means a better outcome.
At baseline, immediately after intervention, 18 months after intervention
Level of emotional regulation
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline Emotion Regulation Questionnaire score after intervention. Minimum score 6, maximum score 30. Higher score means a better outcome.
At baseline, immediately after intervention, 18 months after intervention
Level of inflammation
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on baseline innate immunity-related proteins after intervetion, measured in pg/ml.
At baseline, immediately after intervention, 18 months after intervention
Level redox system activity
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline activity of plasma glutathion and metabolites after intervention, measured in mMol/L-
At baseline, immediately after intervention, 18 months after intervention
Hair cortisol level
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on the baseline hair cortisol measure after intervention, measured in pg/mg.
At baseline, immediately after intervention, 18 months after intervention
Heart rate variability
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on baseline herat rate variability after intervetion.
At baseline, immediately after intervention, 18 months after intervention
Level of redox system activity
Lasso di tempo: At baseline, immediately after intervention, 18 months after intervention
Change on baseline activity of enzimes involved in glutathion metabolism after intervention, measured in U/gHb
At baseline, immediately after intervention, 18 months after intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Camille Piguet, Physician, Geneva University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

12 febbraio 2019

Completamento primario (Anticipato)

30 novembre 2022

Completamento dello studio (Anticipato)

30 novembre 2022

Date di iscrizione allo studio

Primo inviato

16 maggio 2019

Primo inviato che soddisfa i criteri di controllo qualità

14 gennaio 2021

Primo Inserito (Effettivo)

15 gennaio 2021

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 gennaio 2021

Ultimo aggiornamento inviato che soddisfa i criteri QC

14 gennaio 2021

Ultimo verificato

1 gennaio 2021

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2018-017731

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Fatica

Prove cliniche su Minfulness-based Intervention

Sottoscrivi